BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2006
View Archived Issues
FabI inhibitors shown effective against staphylococci
Read More
AN-0900's encouraging results in preclinical models of anthrax infection
Read More
ATH-18534: targets pneumonia bacterial pathogenicity
Read More
Hemispherx Biopharma reports on "excellent year"
Read More
Dusa to acquire Sirius Laboratories
Read More
Fast track designation for HuMax-EGFr in head and neck cancer
Read More
Wyeth and Trubion form strategic alliance in inflammatory disease and cancer
Read More
Bristol-Myers Squibb files sBLA for third-party manufacturing of Orencia
Read More
Sativex cleared for U.S. phase III trials
Read More
Neose Technologies cleared to study NE-180 in phase I trial
Read More
Morphotek inlicenses antibody for mesothelin-expressing cancers
Read More
Versatile topical DNA vaccine undergoes preliminary clinical study in HIV
Read More
Northfield to receive defense appropriation for PolyHeme development
Read More
Orphan drug designation for CellCept in myasthenia gravis
Read More
Ecopia BioSciences seeks clearance for phase I Canadian study of ECO-4601
Read More
Epix ramps up phase IIa study of fibrin-binding imaging agent EP-2104R
Read More
Bayer purchases GlaxoSmithKline's European telmisartan rights
Read More
Gardasil submitted for Australian approval
Read More
KW-3902 improves fluid elimination and renal function in heart failure patients
Read More
Novel agents with potential in the treatment of anxiety, depression, etc. revealed in recent patents
Read More
Climara Pro approved for prevention of postmenopausal osteoporosis
Read More
Recent patents describe possible new agents for diabetes
Read More
Phase II trial investigates iPlex for myotonic muscular dystrophy
Read More
Novel treatments for cancer subject of several recent patents
Read More
Phase II trial for NT-501 in dry AMD
Read More
Success of universal toddler Havrix(R) vaccination program in endemic hepatitis A population
Read More
Synergistic antidepressant effects seen with M-100907 and fluoxetine
Read More